David Gütig

Title: David Gütig: Innovator in DNA Methylation Detection

Introduction

David Gütig is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of molecular biology, particularly in the detection of cytosine methylations in DNA samples. With a total of 2 patents, Gütig's work has the potential to advance our understanding of genetic regulation and epigenetics.

Latest Patents

Gütig's latest patents include a method for the detection of cytosine methylations in immobilized DNA samples. This innovative method involves isolating genomic DNA from cells and binding it to a surface. The DNA is then treated with bisulfite, which converts cytosine into a different base, while leaving 5-methylcytosine unchanged. After washing away the reagents, selected segments of the immobilized DNA are amplified through a polymerase reaction, allowing for detailed sequence analysis.

Career Highlights

David Gütig is currently associated with Epigenomics AG, a company focused on developing innovative diagnostic solutions in the field of epigenetics. His work at Epigenomics AG has positioned him as a key player in the advancement of DNA analysis technologies.

Collaborations

Gütig has collaborated with notable colleagues such as Kurt Berlin and Matthias Ballhause. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

David Gütig's contributions to the detection of cytosine methylations in DNA represent a significant advancement in molecular biology. His innovative methods and collaborations continue to push the boundaries of genetic research.